Platelet-rich plasma in Achilles tendon healing 2 (PATH-2) trial: statistical analysis plan for a multicentre, double-blinded, parallel-group, placebo-controlled randomised clinical trial
<h4>Background</h4> <p>There has been a recent steep growth in platelet-rich plasma (PRP) use for musculoskeletal conditions, but findings from high quality clinical trial data are lacking in the literature. Here, we describe the statistical analysis plan (SAP) for the Platelet-ri...
Váldodahkkit: | Schlüssel, M, Keene, D, Wagland, S, Alsousou, J, Lamb, S, Willett, K, Dutton, S |
---|---|
Materiálatiipa: | Journal article |
Giella: | English |
Almmustuhtton: |
BioMed Central
2018
|
Geahča maid
-
Platelet rich Plasma in Achilles Tendon Healing 2 (PATH-2) trial: protocol for a multicentre, participant and assessor-blinded, parallel-group randomised clinical trial comparing platelet-rich plasma (PRP) injection versus placebo injection for Achilles tendon rupture
Dahkki: Alsousou, J, et al.
Almmustuhtton: (2017) -
Platelet rich plasma injection for acute Achilles tendon rupture: PATH-2 randomised, placebo controlled, superiority trial
Dahkki: Keene, D, et al.
Almmustuhtton: (2019) -
Platelet rich plasma injection for acute Achilles tendon rupture: two-year follow-up of the PATH-2 randomised, placebo-controlled, superiority trial
Dahkki: Keene, D, et al.
Almmustuhtton: (2022) -
Platelet-rich plasma injection for adults with acute Achilles tendon rupture: the PATH-2 RCT
Dahkki: Alsousou, J, et al.
Almmustuhtton: (2019) -
Characteristics of L-PRP preparations for treating Achilles tendon rupture within the PATH-2 study
Dahkki: Harrison, P, et al.
Almmustuhtton: (2020)